RecruitingNCT06126016

A Observational Study to Evaluate the Efficacy and Safety of Pacitol Inj.

A Multi-center, Prospective, Non-interventional, Observational Study to Evaluate the Efficacy and Safety of Pacitol Inj.(Paricalcitol) for Secondary Hyperparathyroidism With Stage 5D Chronic Kidney Disease (CKD 5D) Receiving Hemodialysis


Sponsor

Boryung Pharmaceutical Co., Ltd

Enrollment

1,000 participants

Start Date

Oct 19, 2023

Study Type

OBSERVATIONAL

Conditions

Summary

The purpose of this study is to evaluate the efficacy and safety of pacitol Inj.(paricalcitol) for secondary hyperparathyroidism with stage 5D chronic kidney disease (CKD 5D) receiving hemodialysis


Eligibility

Min Age: 19 Years

Plain Language Summary

Simplified for easier understanding

This observational study is evaluating how well and how safely Pacitol Injection (a vitamin D-related drug) works in patients on kidney dialysis who have overactive parathyroid glands — a common complication of chronic kidney disease. **You may be eligible if:** - You are a dialysis patient with overactive parathyroid glands (secondary hyperparathyroidism) due to chronic kidney disease - Your doctor has already planned to prescribe Pacitol Injection as part of your standard care - You can understand and agree to participate **You may NOT be eligible if:** - You have a known allergy to Pacitol or its ingredients - You have signs of vitamin D toxicity or high calcium levels - You are pregnant or breastfeeding - You have a parathyroid tumor and are scheduled for surgery to remove it - You have been on another clinical trial drug within the past 12 weeks Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.


Locations(1)

DongGuk university Ilsan hospital

Goyang-si, Gyeonggi-do, South Korea

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06126016


Related Trials